Viveve Medical (NASDAQ: VIVE) and Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, profitability, analyst recommendations, dividends, risk, valuation and institutional ownership.

Valuation & Earnings

This table compares Viveve Medical and Invivo Therapeutics Holdings Corp’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Viveve Medical $8.90 million 14.37 -$20.93 million ($2.24) -2.95
Invivo Therapeutics Holdings Corp N/A N/A -$25.77 million N/A N/A

Viveve Medical has higher revenue and earnings than Invivo Therapeutics Holdings Corp.

Analyst Ratings

This is a summary of recent ratings and target prices for Viveve Medical and Invivo Therapeutics Holdings Corp, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Viveve Medical 0 0 5 0 3.00
Invivo Therapeutics Holdings Corp 0 1 0 0 2.00

Viveve Medical presently has a consensus price target of $12.80, indicating a potential upside of 93.65%. Invivo Therapeutics Holdings Corp has a consensus price target of $6.00, indicating a potential upside of 380.00%. Given Invivo Therapeutics Holdings Corp’s higher probable upside, analysts plainly believe Invivo Therapeutics Holdings Corp is more favorable than Viveve Medical.

Insider & Institutional Ownership

61.8% of Viveve Medical shares are owned by institutional investors. 35.1% of Viveve Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.


This table compares Viveve Medical and Invivo Therapeutics Holdings Corp’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Viveve Medical -255.11% -232.94% -93.93%
Invivo Therapeutics Holdings Corp N/A -96.88% -80.44%


Viveve Medical beats Invivo Therapeutics Holdings Corp on 6 of the 10 factors compared between the two stocks.

Viveve Medical Company Profile

Viveve Medical, Inc. designs, develops, manufactures and markets a medical device, Geneveve, for the non-invasive treatment of vaginal laxity, for improved sexual function, and for vaginal rejuvenation. The Company’s, Geneveve, is a non-invasive solution for vaginal laxity, which includes three components: the Viveve System (a radio frequency (RF), generator housed in a table-top console), a reusable handpiece and a single-use treatment tip, as well as several other consumable accessories. Physicians attach the single-use treatment tip to the handpiece, which is connected to the console. The generator authenticates the treatment tip and programs the system for the desired treatment without further physician intervention. The treatment is performed in a physician’s office, in less than 30 minutes, and does not require the use of anesthesia. Geneveve is indicated for use in general surgical procedures for electrocoagulation and hemostasis in the United States.

Invivo Therapeutics Holdings Corp Company Profile

InVivo Therapeutics Holdings Corp., formerly Design Source, Inc., is a research and clinical-stage biomaterials and biotechnology company. The Company is engaged in developing and commercializing biopolymer-scaffolding devices for the treatment of spinal cord injuries (SCI). The Company’s approach to treating acute SCIs is based on its investigational Neuro Spinal Scaffold implant, an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord contusion and is intended to treat acute spinal cord injury. The Neuro-Spinal Scaffold consists of biocompatible and bioresorbable polymers, which include poly lactic-co-glycolic acid (PLGA) and Poly-L-Lysine (PLL). The Company is also evaluating other technologies and therapeutics that may be complementary to its development of the Neuro-Spinal Scaffold implant. The Company has a clinical development program for acute SCI and a preclinical development program for chronic SCI.

Receive News & Ratings for Viveve Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viveve Medical Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.